Dalla conferenza emergerà un messaggio forte diretto alla società: i virus hanno un potente impatto economico, politico e sociale, ma la scienza e la tecnologia sono sempre più in grado di contenerne la minaccia e i danni, sviluppando nuovi vaccini preventivi e terapie mirate, basate sulle conoscenze più avanzate della biologia molecolare." />
Feed RSS: Molecularlab.it NewsiCalendar file
Appuntamenti

Virus: il nemico invisibile

Scienziati di fama internazionale racconteranno come i virus si sono evoluti e come gli esseri umani hanno imparato nel tempo a difendersi da queste minacce invisibili; spiegheranno come un virus penetra nelle cellule dell’organismo aggirandone i sistemi di difesa; e chiariranno qual è il ruolo dei virus nell’insorgenza del cancro.
Si parlerà inoltre della speranza di un vaccino per l’AIDS, della prevenzione delle pandemie e dei virus emergenti, ma anche dei cosiddetti "virus buoni", utilizzati nello sviluppo di terapie genetiche e antitumorali.
Dalla conferenza emergerà un messaggio forte diretto alla società: i virus hanno un potente impatto economico, politico e sociale, ma la scienza e la tecnologia sono sempre più in grado di contenerne la minaccia e i danni, sviluppando nuovi vaccini preventivi e terapie mirate, basate sulle conoscenze più avanzate della biologia molecolare.

Dettagli

EventoWELCOME ADDRESSES
Umberto Veronesi, Conference President
Giovanni Bazoli, President Giorgio Cini Foundation
Marco Tronchetti Provera, President Silvio Tronchetti Provera Foundation
Chiara Tonelli, Conference Secretary general
OPENING LECTURES
Luc Montagnier, 2008 Nobel Prize in Medicine. World Foundation Aids Research and Prevention, UNESCO, Paris, France
Robert Gallo, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, USA

MON, SEP. 20
1st Day

MORNING SESSION chaired by:
Claudio Basilico, Department of Microbiology, NYU School of Medicine, New York, USA ,
Chiara Tonelli, Department of Biomolecular Sciences and Biotechnology, University of Milan, Italy

VIRUS IN EVOLUTION
Viruses: the invisible enemy revealed - Dorothy Crawford, University of Edinburgh, UK
Virus Hunting - Nathan Wolfe, Stanford University, USA
Endogenous viral sequences and their evolution - John Coffin, Department of Microbiology, Tufts University, Boston, USA.

ANIMAL AND PLANT VIRUSES
Animals, humans and viruses: novel perspectives for managing global threats - Ilaria Capua, Istituto Zooprofilattico Sperimentale delle Venezie, Italy
Viruses, Insects and Hunger - Shivaji Pandey, FAO, Rome, Italy
The battle against plant viruses - Wilhelm Gruissem, Department of Biology, Plant Biotechnology, ETH, Zurich

AFTERNOON SESSION chaired by:
Giuseppe Ippolito, National Institute for Infectious Diseases Lazzaro Spallanzani, Rome, Italy ,
Gianpiero Sironi, Department of Biomolecular Sciences and Biotechnology, Università degli Studi di Milano, Italy

VIRUS AND MANKIND
Hepatitis C: towards control and eradication - Charles Rice, Center for the Study of Hepatitis C, The Rockefeller University, NY, USA
Pandemic influenza - Adolfo García-Sastre, Global Health and Emerging Pathogens Institute, Mount Sinai School of Medicine, New York, USA
Emerging Zoonotic Viruses: Response and Preparedness - Heinrich Feldmann, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, USA
Viruses and immunity: molecular pirates and the challenge of a global alliance - Alberto Mantovani , Istituto Clinico Humanitas, Università degli Studi di Milano
Vaccines to address the needs of 21st century society - Rino Rappuoli, Novartis Vaccines and Diagnostics, Siena, Italy


TUE, SEP. 21
2nd Day

MORNING SESSION chaired by:
Luigi Chieco-Bianchi, Department of Oncology and Surgical Sciences, University of Padova, Italy ,
Maria Ines Colnaghi, Italian Association for Cancer Research

VIRUS, CANCER AND THERAPY - Italian Association for Cancer Research Symposium
Viruses and Cancer - Robin Weiss, Division of Infection and Immunity, University College London, UK.
HTLV-1 encoded proteins that favor viral persistence in humans - Genoveffa Franchini , Animal Models & Retroviral Vaccines Section, National Cancer Institute, Bethesda, USA
Chronic viral hepatitis and liver cancer - Harvey Alter, Department of Transfusion Medicine, National Institute of Health, Bethesda, USA.
The good viruses, precious allies of man - Inder Verma, The Salk Institute for Biological Sciences, La Jolla, CA, USA.

AFTERNOON SESSION chaired by:
Umberto Veronesi, European Institute of Oncology, Milan, Italy,
Telmo Pievani, Department of Human Sciences for Education, University of Milan Bicocca, Italy

VIRUS AND SOCIETY
Transatlantic Partnerships to Counter Biological Threats - Marc Ostfield, U.S. Department of State, Washington, USA
Social and economic impact - Barry Bloom, Department of Infectious Diseases, Harvard School of Public Health, Boston, USA. (INVITED)
Overcoming a virus nightmare: why and how companies protect their people at all cost - Manuela Kron , Nestlè, Italy
The visible virus: media representation of virus and pandemics - Massimiano Bucchi, Department of Sociology of Science, University of Trento, Italy

CLOSING
Umberto Veronesi, European Institute of Oncology, Milan, Italy
Chiara Tonelli, Department of Biomolecular Sciences and Biotechnology, University of Milan, Italy

Quando e dove

Inizio: 19/09/2010
Fine: 21/09/2010

Fondazione Giorgio Cini
Isola San Giorgio Maggiore Venezia (VE), Italy

Ulteriori informazioni

http://www.thefutureofscience.com/